Regulatory measures for implementing new medical devices. Recalling Boneloc®

Danish Medical Bulletin

Volumn 52, Issue 1, 2005, Pages 11-17

  Riehmann, Morten ^a,b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b NONE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BONE CEMENT; METHACRYLIC ACID METHYL ESTER; POLY(METHYL METHACRYLATE);

ARTHROPLASTY; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; CLINICAL PRACTICE; CLINICAL STUDY; DENMARK; EQUIPMENT DESIGN; EUROPEAN UNION; FINLAND; INFORMATION SYSTEM; JOINT PROSTHESIS; LAW; MARKETING; NORWAY; OUTCOMES RESEARCH; PROFESSIONAL STANDARD; PROSTHESIS FAILURE; QUALITY CONTROL; RELIABILITY; RESEARCH ETHICS; SAFETY; SWEDEN;

BONE CEMENTS; DENMARK; DEVICE APPROVAL; EUROPEAN UNION; HUMANS; METHACRYLATES; SCANDINAVIA;

EID: 27344446527     PISSN: 16039629     EISSN: 16039629     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Citron P. Medical devices: factors adversely affecting innovation. J Biomed Mat Res 1996; 32 (1): 1-2.
2. Riehmann M, Gasser TC, Bruskewitz RC. The Hydroflex penile prosthesis: a test case for the introduction of new urological technology. J Urol 1993; 149 (5): 1304-7.
3. Miller AS, Willard V, Kline K, Tarpley S, Guilotte J, Lawler FH, Pendell GM. Absence of longitudinal changes in rheumatologic parameters after silicone breast implantation: a prospective 13-year study. Plast Reconstr Surg 1998; 102 (7): 2299-303.
4. Hansen D, Jensen JS. Additional mechanical tests of bone cements. Acta Orthop Belg 1992; 58 (3): 268-71.
5. Havelin LI, Espehaug B, Vollset SE, Engesæter LB, Langeland N. The Norwegian Arthroplasty Register. A survey of 17,444 hip replacements 1987-1990. Acta Orthop Scand 1993; 64 (3): 245-51.
6. Homsy CA, Tullos HS, Anderson MS, Diferrante NM, King JW. Some physiological aspects of prosthesis stabilization with acrylic polymer. Clin Orthop 1972; 83 Mar-Apr: 317-28.
7. Feith R. Side-effects of acrylic cement implanted into bone. A histological, (micro)angiographic, fluorescence-microscopic and autoradiographic study in the rabbit femur. Acta Orthop Scand Suppl 1975; 61: 3-136.
8. Lindwer J, van den Hooff A. The influence of acrylic cement on the femur of the dog. A histological study. Acta Orthop Scand 1975; 46 (4): 657-71.
9. Reckling FW, Dillon WL. The bone-cement interface temperature during total joint replacement. J Bone Joint Surg [Am] 1977; 59 (1): 80-2.
10. Linder L. Reaction of bone to the acute chemical trauma of bone cement. J Bone Joint Surg [Am] 1977; 59 (1): 82-7.
11. Schoenfeld CM, Conard GJ, Lautenschlager EP. Monomer release from methacrylate bone cements during simulated in vivo polymerization. J Biomed Mater Res 1979; 13 (1): 135-47.
12. Mjöberg B. Loosening of the Cemented Hip Prosthesis. Acta Orthop Scand Suppl 1986; 57 (221): 3-40.
13. Nissen J N, Corydon L. Corneal ulcer after exposure to vapours from bone cement (methyl methacrylate and hydroquinone). Int Arch Occup Environ Health 1985; 56 (2): 161-5.
14. Darre E, Jørgensen LG, Vedel P, Jensen JS. Breathing zone concentrations of methylmethacrylate monomer during joint replacement operations. Pharmacol Toxicol 1992; 71 (3): 198-200.
15. Kindt-Larsen T, Smith DB, Jensen JS. Innovations in acrylic bone cement and application equipment. J Appl Biomat 1995; 6 (1): 75-83.
16. Thomsen OØ, Riis P. Gastroenterology in the last decennia and initiatives in medical ethics: coincidence or linkage? Scand J Gastroenterol Suppl 1996; 216: 208-17.
17. Riis P. Forskning under etisk kontrol. Ugeskr Læger 1976; 138 (36): 2195-200.
18. World Medical Association (WMA) Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. Adopted by the 18th World Medical Assembly in Helsinki, Finland in June 1964, and amended by the 29th World Medical Assembly in Tokyo, Japan in October 1975, and the 35th World Medical Assembly in Venice, Italy in October 1983, the 41th World Medical Assembly in Hong Kong in September 1989, the 48th General Assembly in Somerset West, the Republic of South Africa in October 1996, and 52nd General Assembly in Edinburgh, Scotland, October 7th, 2000.
19. Ludgate SM, Potter DC. European directives on medical devices. Br Med J 1993; 307 (6902): 459-60.
20. Crisp S. The medical device directives and their impact on the development and manufacturing of medical implants. Proc Inst Mech Eng H 1996; 210 (4): 233-9.21.
21. Council Directive 90/385/EEC of 20 June 1990, on the approximation of the laws of the Member States relating to Active Implantable Medical Devices Directive. Commission of the European Communities. Off J Eur Comm 1990; L 189.
22. Council Directive 93/42/EEC of 14 June 1993, concerning Medical Devices. Commission of the European Communities. Off J Eur Comm 1993; L 169.
23. Directive 98/79/EC of the European Parliament and of the Council of October 27, 1998 on In-vitro Diagnostic Medical Devices.
24. Holm S, Rossel P. What does the Danish population know about research ethical committees? Ugeskr Læger 1996; 158 (31): 4383-4.
25. Thanner J, Freij-Larsson C, Kärrholm J, Malchau H, Wesslen B. Evaluation of Boneloc® Chemical and mechanical properties, and a randomized clinical study of 30 total hip arthroplasties. Acta Orthop Scand 1995; 66 (3): 207-14.
26. Wykman AGM. Acetabular cement temperature in arthroplasty. Effect of water cooling in 19 cases. Acta Orthop Scand 1992; 63 (5): 543-4.
27. Wykman AGM, Sandersjoo G A. Low polymerization temperature with Boneloc®. In vivo measurements in 11 hip replacements. Acta Orthop Scand 1995; 66 (3): 218-9.
28. Jensen JS, Bødtker S, Kramhøft M, Thomsen PB, Pedersen D, Nielsen K. Clinical results after 2-4 years with a new MMA/DMA/IBMA bone cement used for fixation of the femoral stem. Hip Intern 1995; 5 (1): 31-6.
29. Jensen JS, Sylvest A, Trap B, Jensen JC. Genotoxicity of acrylic bone cements. Pharmacol Toxicol 1991; 69 (5): 386-9.
30. Jensen JS, Trap B, Skydsgaard K. Delayed contact hypersensitivity and surgical penetration with acrylic bone cement. Acta Orthop Scand 1991; 62 (1): 24-8.
31. Trap B, Wolff P, Jensen JS. Acrylic bone cements: residuals and extractability of methacrylate monomers and aromatic amines. J Appl Biomat 1992; 3 (1): 51-7.
32. Sylvest A, Kramhoft M, Jensen JS, Thomsen LD, Jensen JC. Monomer in central venous blood during polymerization of bone cements, and toxicity of a new monomer. Eur J Exp Musculoskel Res 1992; 1: 47-50.
33. Furnes O, Lie SA, Havelin LI, Vollset SE, Engesæter LB. Exeter and Charnley arthroplasties with Boneloc® or high viscosity cement. Comparison of 1,127 arthroplasties followed for 5 years in the Norwegian Arthroplasty Register. Acta Orthop Scand 1997; 68 (6): 515-20.
34. Havelin LI, Espehaug B, Vollset SE, Engesæter LB. The effect of the type of cement on early revision of cement total hip of Charnley total hip prostheses: a review of eight thousand five hundred and seventy-nine primary arthroplasties from the Norwegian Arthroplasty Register. J Bone Joint Surg [Am] 1995; 77 (10): 1543-50.
35. Havelin LI, Espehaug B, Engesæter LB, Vollset SE. The effect of the type of cement on the survival of total hip prostheses. Proceedings of the annual meeting of the Norwegian Orthopedic Association, Oslo, Norway. October 1994.
36. Linder L. Boneloc® - The Christiansen experience revisited. Acta Orthop Scand 1995; 66 (3): 205-6.
37. Suominen S. Early failure with Boneloc® bone cement. 4/8 femoral stems loose within 3 years. Acta Orthop Scand 1995; 66 (1): 13.
38. Thomsen PB, Hansen TB, Kampmann J, Klamer A. BonelocR cemented Exeter hip arthroplasty - five years follow up. Abstract. Danish Orthopedic Society Bulletin 1996; 25 (6): 18.
39. Robertsen K, Pedersen D, Nielsen K. Boneloc® cement and the Exeter hip. Five years results. Abstract. Danish Orthopedic Society Bulletin 1996; 25 (6): 17.
40. Daubjerg K, Kaltoft M. Aseptic loosening and clinical result in total hip replacement with the use of Boneloc®, Simplex or Palacos® cement. Abstract. Danish Orthopedic Society Bulletin 1997; 26 (3): 46.
41. Riegels-Nielsen P, Sørensen L, Morgen Andersen H, Lindequist S. Boneloc® cemented total hip prostheses: loosening in 28/43 cases after 3-38 months. Acta Orthop Scand 1995; 66 (3): 215-7.
42. Nilsen AR, Wiig M. Total hip arthroplasty with Boneloc®. Loosening in 102/157 cases after 0.5-3 years. Acta Orthop Scand 1996; 67 (1): 57-9.
43. Furnes A, Lie SA, Havelin LI, Engesæter LB, Vollset SE. The economic impact of failures in total hip replacement surgery: 28,997 cases from the Norwegian Arthroplasty Register, 1987-1993. Acta Orthop Scand 1996; 67 (2): 115-21.
44. Wedderkopp N, Ranberg FA, Andersen MB, Termansen NB. Aseptic loosening of BonelocR cemented hip prostheses. Int Orthop 1997; 21 (2): 87-90.
45. Nilsson KG, Dalen T. Inferior performance of Boneloc® bone cement in total knee arthroplasty. A prospective randomized study comparing Boneloc® with Palacos® using radiostereometry (RSA) in 19 patients. Acta Orthop Scand 1998; 69 (5): 479-83.
46. Nimb L, Stürup J, Jensen JS. Improved cortical histology after cementation with a new MMA-DMA-IBMA bone cement: an animal study. J Biomed Mater Res 1993; 27 (5): 565-74.
47. Stürup J, Nimb L, Jensen JS. Blood perfusion and remodelling activity in canine tibial diaphysis after filling with a new bone cement compared to bone wax and poly (methyl methacrylate) cement. Biomaterials 1995; 16 (11): 845-8.
48. Engh CA, McGovern TF, Bobyn JD, Harris WH. A quantitative evaluation of periprosthetic bone-remodeling after cementless total hip arthroplasty. J Bone Joint Surg [Am] 1992; 74 (7): 1009-20.
49. Ryd L. Micromotion in knee arthroplasty. A roentgen stereophotogrammetric analysis of tibial component fixation. Acta Orthop Scand Suppl 1986; 57 (220): 1-80.
50. Ryd L, Albrektsson BE, Carlsson L, Dansgard F, Herberts P, Lindstrand A, Regner L, Larsen ST. Roentgen stereophotogrammetric analysis as a predictor of mechanical loosening of knee prostheses. J Bone Joint Surg [Br] 1995; 77 (3): 377-83.
51. Kärrholm J, Malchau H, Snorrason F, Herberts P. Micromotion of femoral stems in total hip arthroplasty. A randomized study of cemented, hydroxyapatite-coated and porous-coated stems with roentgen stereophotogrammetric analysis. J Bone Joint Surg [Am] 1994; 76: 1692-705.
52. Kärrholm J, Borssen B, Lowenhielm G, Snorrason F. Does early micromotion of femoral stem prostheses matter? 4-7-year stereoradiographic follow-up of 84 cemented prostheses. J Bone Joint Surg [Br] 1994; 76: 912-7.
53. Riegels-Nielsen P. Personnel communication. The Danish Orthopedic Society Meeting, Copenhagen, October 29-30, 1993.
54. Sørensen L, Andersen HM, Riegels-Nielsen P. Early experience with the Boneloc® cement in total hip prostheses. Abstract. Danish Orthopedic Society Bulletin 1994; 23 (6): 31.
55. Nielsen LN. Rapport on the role of the Danish National Board of Health in the Boneloc® case. May 1998.
56. Randall H. Post-marketing surveillance and vigilance for medical devices: the European approach. Drug Saf 2001; 24 (12): 869-72.
57. Malchau H. On the Importance of Stepwise Introduction of New Hip Implant Technology. Assessment of Total Hip Replacement Using Clinical Evaluation, Radiostereometry, Digitized Radiography, and a National Hip Registry. Thesis. Göteborg 1995.